share_log

領航醫藥生物科技:(1) 修訂可換股債券之條款及條件; (2)授出特別授權發行換股股份; (3) 附屬公司層面之關連交易; 及(4) 股東特別大會通告

INNOVATIVE PHAR: (1) AMENDMENT OF THE TERMS AND CONDITIONS OF THE CONVERTIBLE BONDS; (2) GRANT OF SPECIFIC MANDATE TO ISSUE CONVERSION SHARES; (3) CONNECTED TRANSACTION AT SUBSIDIARY LEVEL; AND (4) NOTICE OF SPECIAL GENERAL MEETING

Jul 13, 2021 04:52
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more